Alcohol-related liver diseases (ALD)

Česká verze

Authors: Jiří Ehrmann; Květoslava Aiglová; Ondřej Urban; Silvia Cveková; Pavol Dvoran
Authors place of work: II. interní klinika – gastroenterologická a geriatrická LF UP a FN Olomouc
Published in the journal: Vnitř Lék 2020; 66(5): 39-51
Category: Přehledové články

Summary

The main aim of this educational article ( narrative review ) is to reflect clinical practice guidelines of the European Association for the Study of the Liver (EASL) published in J Hepatol 2018, contrasting with the 2012 guidelines especialy in the new terminology of alcohol-related liver diseases (ALD). The strong emphasis on prevention of alcohol use disorders (AUD) may be exert at all stages of public health care. Another aim of the article are ALD history, epidemiology, metabolism of alcohol and clinical pictures of ALD.

Keywords:

alcohol – liver – abusus – EASL guidelines – disorders

Zdroje

1. Pandida RJ. Introduction to alcohol studies: 75 years in review. Journal of Studies on Alcohol and Drugs March 2014; Suppl. 17; 5–7.

2. European Association for the Study of the Liver. EASL clinical practice guidelines: management of alcohol‑related liver disease. J Hepatol 2018; 69; 154–181.

3. Brodanová M, Ehrmann J. Historie. In: Hůlek P, Urbánek P et al (eds.) Hepatologie. 3. vydání. Praha: Grada Publishing 2018; 3–16.

4. Franken FH, Falk H. History of liver disease. In: McIntyre N, Benhamou JP, Bircher J et al (eds.): Oxford Textbook of Clinical Hepatology. Oxford University Press 1991; 1455–1460.

5. Candon PM, Ward JH, Pandina RJ. The Journal of Studies on Alcohol and Drugs and the Rutgers Center of Alcohol Studies. A History of the evolution of alcohol research. J Stud Alcohol Drugs 2014; Suppl. 17; 8- 17.

6. Connor CL. Cirrhosis of the liver. Quarterly J Studies Alcohol 1940; 1; 95–104.

7. Mak KM, Leo MA, Liber CS Alcohol liver injury in babbons: transformation of lipocytes to transitional cells. Gastroenterology 1984; 87; 188–200.

8. Bissell DM. Commentary on article. Mak H et al. Alcohol liver injury in babbons: transmformation of lipycytes to transitional cells. enterology. J Hepatol. 2004; 40; 887–890.

9. Zima T, Fialová L, Mestek O, et al. Oxidative stress, metabolism of etanol and alcohol‑related disease. J Biomed Sci 2001; 8; 59–70.

10. Schneiderka P. Metabolismus a vylučování etylalkoholu. In: Hůlek P, Urbánek P (eds.): Hepatologie 3. vydání. Praha: Grada Publishing 2018, 339–342.

11. WHO. Global Status Report on non communicable disease 2014. WHO Library Cataloguing‑in‑Publication Data; 2014.

12. OECD. Alcohol Consumption among adults. In: Healthat a Glance 2017; 1217; 72–73.

13. Routhu M, Hosák L. Alkoholismus a abúzus alkoholu. In: Hůlek P, Urbánek P (eds.): Hepatologie 3. vydání. Praha: Grada Publishing 2018, 364–375.

14. Ehrmann J, et al. Alkoholové jaterní poškození. Postgrad Gastroent Hepatol 2015; 1; 206–2017.

15. Ehrmann J, et al. Alkoholem podmíněné jaterní poškození. In: Hůlek P, Urbánek P (eds.): Hepatologie 3. vydání. Praha: Grada Publishing 2018, 336–362.

16. WHO. Food based dietary guidelines 2003.

17. DHHS, DoA.2015–2020 Dietary Guidelines for Americans. In 8th ed. http://health.gov/ dietaryguidelines/2015/guidelines /2015.

18. WHO. Global status report on alcohol. Geneva: WHO department of Mental Health and Substance abuse; 2011.

19. Association APOD. American Psychiatric Association Substance use and addiction – related disorders. In Diagnostic and Statistical Manual of Mental Disorders, 5th Edison. American Psychiatric Association 2013; 481–589.

20. Rehm J, et al. Alcohol use disorders in primary health care: what do we know and where do we go? Alcohol 2016; 51; 422–427.

21. Burton R, Sheron N. No level of alcohol consumption improves health. Lancet 2018; 392; 987–988.

22. Ehrmann jr. J. Alkoholická jaterní cirhóza. In: Ehrmann jr. J, Schneiderka P, Ehrmann J (eds.): Alkohol a játra. Praha: Grada Publishing 2006, 69–87.

23. Sherlock S, Dooley J. Alkohol a játra. In: Nemoci jater a žlučových cest. Český překlad 11. vydání – Diseases of the Liver and Biliary System. Hradec Králové, O. Čermáková 2004, 381–398.

24. Filingery V, et al. Restrospective analysis of 1.011 percutaneous liver biopsies in performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications? Eur Rev Med Phat Sci 2016; 20; 3609–3617.

25. Ehrmann jr. J, Aiglová K. Jaterní biopsie. In: Hůlek P, Urbánek P (eds.): Hepatologie 3. vydání. Praha: Grada Publishing 2018, 121–139.

26. Ludwig J, et al. Non‑alcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55; 434–438.

27. Sakhuja P. Pathology of alcoholic liver disease, can it be differentiated from non alcoholic steatohepatitis? World J Gastroenterol 2014; 20; 1674–1679.

28. Schneiderka M, et al. Laboratorní vyšetření a metody detekce a stanovení etanolu v biologickém materiálu. In: Hůlek P, Urbánek P (eds.): Hepatologie 3. vydání. Praha: Grada Publishing 2018, 347–350.

29. Zieve L. Jaundice, hyperlipidemia, and hemolyticanemia: here to for eunrecognized syndrome associated with fatty liver and cirrhosis. Ann Intern Med 1958; 48; 471.

30. Deleuran T, et al. Cirrhosis and mortality risk of biopsy‑verified alcoholic pure steatosis and steatohepatitis: a nationwide registry‑based study. Aliment Pharmacol Ther 2012; 35; 1336–1342.

31. Lacnetr C et al: Histological parametres and alcohol abstinence determine long‑term prognosis in patiens with alcoholic liver disease. J Hepatol 2017; 66; 610–618.

32. Kennedy OJ, et al. Systematic review with meta‑analysis: coffee consumption and risk of cirrhosis. Aliment Pharmacol Ther 2016; 43; 562–574.

33. Sherlock S. Nutritional disease. In: Diseases of the Liver and Biliary System. Illionis USA, Charles C Thomas Publisher 1954, 276–304.

34. Menghini G. One‑second needle biopsy of the liver. Gastroenterology 1958; 35; 190.

35. Amstrong MJ, et al. Extrahepatic complication of nonalcoholic fatty liver disease. Hepatology 2014; 59; 1174–1197.

36. Sandahl TD, Jepsen P, Thomsen KL, et al. Incidence and mortality of alcoholic hepatitis in Denmark 1999–2008: a nationwide population based cohort study. J Hepatol 2011; 54: 760–764.

37. Michelena J, Altamirano J, Abraldes JG, et al. Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology 2015; 62: 762–772.

38. Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193–199.

39. Moreau R, Jalan R, Gines P, et al. Acute‑on‑chronic liver failure is a distinct syndrome that develops in patiens with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426–1437.

40. Kribben A, Gerken G, Haag S, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute‑on‑chronic liver failure. Gastroenterology 2012; 142; 782–789.

41. Kjaergard LL, Liu J, Nielsen B, et al. Artificial and bioartificial support systems for acute and acute‑on‑chronic liver failure: a systematic review. JAMA 2003; 289: 217–222.

42. Arroyo V, Moreau R, Kamath PS, et al. Acute‑on‑chronic liver failure in cirrhosis. Nat Rev Dis Primers 2016; 2: 41–160.

43. Heemann U, Treichel U, Loock J et al. Albumin dialysis in cirrhosis with super imposed acute liver injury: a prospective, controlled study. Hepatology 2002; 36; 949–958.

44. Bañares R, Nevens F, Larsen FS, et al. Extracorporal albumin dialysis with the molecular adsorbent recirculating system in acute‑on‑chronic liver failure: the RELIEF trial. Hepatology 2013; 57: 1153–1162.

45. Finkenstedt A, Nachbaur K, Zoller H, et al. Acute‑on‑chronic liver failure: excedent outcomes after liver transplantation but high mortality on the wait list. Liver Transpl 2013; 19: 879–886.

46. Adam R, McMaster P, O’Grady, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. LiverTranspl 2003; 9: 1231–1243.

47. Friedman SL. Liver fibrosis – from bench to bedside. J Hepatol 2003; 38: (Suppl. 1); 38–53.

48. Aiglová K. Noninvasive alteratives of liver biopsy. In Takahashi H (ed.) Liverbiopsy. Rijeka: Intech open Access 2016; 297–304.

49. Jalan J, Olson JC, et al. Acute‑on‑chronic liver failure. J Hepatol 2012; 57; 1336–1348.

50. Trunečka P. Transplantace jater. In: Hůlek P, Urbánek P et al (eds.): Hepatologie 3. vydání. Praha: Grada Publishing 2018, 625–647.

51. Aiglová K. Jaterní fibróza a její diagnostika. Postgrad med 2012; 3; 297–304.

52. Burra P, Senzolo M, Adam R, et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010; 10: 138–148.

53. Addolorato G, Bataller R, Burra P, et al. Liver transplantation for alcoholic liver disease. Transplantation 2016; 100: 981–987.

54. MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis 1986; 6: 221–232.